company background image
LFVN

LifeVantage NasdaqCM:LFVN Stock Report

Last Price

US$4.08

Market Cap

US$51.4m

7D

0.7%

1Y

-50.5%

Updated

22 May, 2022

Data

Company Financials +
LFVN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends2/6

LFVN Stock Overview

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products.

LifeVantage Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LifeVantage
Historical stock prices
Current Share PriceUS$4.08
52 Week HighUS$8.66
52 Week LowUS$3.80
Beta1.39
1 Month Change-3.77%
3 Month Change-25.14%
1 Year Change-50.54%
3 Year Change-63.60%
5 Year Change8.22%
Change since IPO-83.35%

Recent News & Updates

May 05

LifeVantage: Soft Quarter, New Dividend Policy, EPS +9% Than Street Expectations

29% net cash of current market capital. Announced first quarterly dividend of $0.03 per share. $28.1 million available under the share repurchase authorization. Revised guidance for 2022. LifeVantage is trading at a P/E of only 4.6x [cash adjusted], with 121% potential upside.

Apr 29
LifeVantage (NASDAQ:LFVN) Might Be Having Difficulty Using Its Capital Effectively

LifeVantage (NASDAQ:LFVN) Might Be Having Difficulty Using Its Capital Effectively

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...

Shareholder Returns

LFVNUS Personal ProductsUS Market
7D0.7%-1.4%-2.7%
1Y-50.5%-26.6%-12.9%

Return vs Industry: LFVN underperformed the US Personal Products industry which returned -26.6% over the past year.

Return vs Market: LFVN underperformed the US Market which returned -12.9% over the past year.

Price Volatility

Is LFVN's price volatile compared to industry and market?
LFVN volatility
LFVN Average Weekly Movement6.9%
Personal Products Industry Average Movement10.0%
Market Average Movement7.8%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market2.9%

Stable Share Price: LFVN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: LFVN's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a263Steve Fifehttps://www.lifevantage.com

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name.

LifeVantage Fundamentals Summary

How do LifeVantage's earnings and revenue compare to its market cap?
LFVN fundamental statistics
Market CapUS$51.37m
Earnings (TTM)US$9.44m
Revenue (TTM)US$210.19m

5.4x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LFVN income statement (TTM)
RevenueUS$210.19m
Cost of RevenueUS$38.55m
Gross ProfitUS$171.65m
Other ExpensesUS$162.20m
EarningsUS$9.44m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.75
Gross Margin81.66%
Net Profit Margin4.49%
Debt/Equity Ratio0%

How did LFVN perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

n/a

Payout Ratio

Valuation

Is LifeVantage undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


5.44x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: LFVN ($4.08) is trading above our estimate of fair value ($2.55)

Significantly Below Fair Value: LFVN is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: LFVN is good value based on its PE Ratio (5.4x) compared to the US Personal Products industry average (15.5x).

PE vs Market: LFVN is good value based on its PE Ratio (5.4x) compared to the US market (15.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate LFVN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: LFVN is good value based on its PB Ratio (1.5x) compared to the US Personal Products industry average (2.2x).


Future Growth

How is LifeVantage forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


2.2%

Forecasted annual revenue growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if LFVN's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if LFVN's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: LFVN's revenue (2.2% per year) is forecast to grow slower than the US market (7.8% per year).

High Growth Revenue: LFVN's revenue (2.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LFVN's Return on Equity is forecast to be high in 3 years time (27.8%)


Past Performance

How has LifeVantage performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


29.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: LFVN has high quality earnings.

Growing Profit Margin: LFVN's current net profit margins (4.5%) are lower than last year (5.3%).


Past Earnings Growth Analysis

Earnings Trend: LFVN's earnings have grown significantly by 29.3% per year over the past 5 years.

Accelerating Growth: LFVN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: LFVN had negative earnings growth (-20%) over the past year, making it difficult to compare to the Personal Products industry average (34.9%).


Return on Equity

High ROE: LFVN's Return on Equity (27.7%) is considered high.


Financial Health

How is LifeVantage's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: LFVN's short term assets ($45.1M) exceed its short term liabilities ($23.6M).

Long Term Liabilities: LFVN's short term assets ($45.1M) exceed its long term liabilities ($14.6M).


Debt to Equity History and Analysis

Debt Level: LFVN is debt free.

Reducing Debt: LFVN has no debt compared to 5 years ago when its debt to equity ratio was 57%.

Debt Coverage: LFVN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: LFVN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is LifeVantage current dividend yield, its reliability and sustainability?

Dividend Score

1/6

Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.94%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: LFVN's dividend (2.94%) is higher than the bottom 25% of dividend payers in the US market (1.58%).

High Dividend: LFVN's dividend (2.94%) is low compared to the top 25% of dividend payers in the US market (4.11%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether LFVN's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if LFVN's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (12.8%), LFVN's dividend payments are thoroughly covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Steve Fife (60 yo)

1.67yrs

Tenure

US$1,610,771

Compensation

Mr. Steven R. Fife, also known as Steve, has served as a President, Director and Chief Executive Officer of LifeVantage Corporation since February 01, 2021. He had been the Chief Financial Officer of Lifev...


CEO Compensation Analysis

Compensation vs Market: Steve's total compensation ($USD1.61M) is above average for companies of similar size in the US market ($USD770.27K).

Compensation vs Earnings: Steve's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

Experienced Management: LFVN's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

Experienced Board: LFVN's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

LifeVantage Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: LifeVantage Corporation
  • Ticker: LFVN
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: US$51.368m
  • Shares outstanding: 12.59m
  • Website: https://www.lifevantage.com

Number of Employees


Location

  • LifeVantage Corporation
  • 3300 North Triumph Boulevard
  • Suite 700
  • Lehi
  • Utah
  • 84043
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/22 00:00
End of Day Share Price2022/05/20 00:00
Earnings2022/03/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.